Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
GLP-1 (Glucagon-Like Peptide-1): GIP (Glucose-Dependent Insulinotropic Peptide): By combining GLP-1 and GIP receptor agonistic activities in one therapeutic (like CT-388), there could be several beneficial outcomes: For CT-388 specifically, the product candidate has been designed to signal through cAMP pathway with minimal to no recruitment of -arrestin
Enhances feelings of vitality, increased energy and well being
Hence, combining non-pharmaceutical strategies with pharmacological therapies is crucial, to prevent the evolution of NASH to cirrhosis and its future devastating sequelae
Batch # printed on the vial label
US$ 25.73
US$ 26.52
US$ 27.74
US$ 20.87
US$ 21.95
US$ 27.87
